COVID Vaccine Distribution: Govt disagrees with Rs 80,000 Crore figure given by Serum Institute

Published On 2020-10-01 04:15 GMT   |   Update On 2020-10-01 04:15 GMT
Advertisement

New Delhi: The government on Tuesday said it does not agree with the calculation that Rs 80,000 crore is needed for distribution of COVID-19 vaccine in India. Health Ministry Secretary Rajesh Bhushan was responding to a question tweeted by Serum Institute of India Chief Executive Officer Adar Poonawalla who asked the government whether it had Rs 80,000 crore over the next one year for distribution of COVID-19 vaccine.

Advertisement
"Quick question; will the government of India have 80,000 crores available, over the next one year? Because that's what @MoHFW_INDIA needs, to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle," Poonawalla had tweeted.
Responding, Bhushan said, "We do not agree by the calculation of Rs 80,000 crore. The government has made a national committee on vaccine experts and five meetings have taken place till now."
"In these meetings, we have mulled over the process of COVID-19 vaccine distribution and the amount required for it in terms of prioritisation of population and the staggered immunisation for this prioritisation.
"We have calculated the amount required in the meetings and currently, that amount is available with the government," said Bhushan. UZM PLB AAR



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News